PFO
CLOV icon

Pathstone Family Office’s Clover Health Investments CLOV Stock Holding History

Pathstone Family Office’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$22.3K Hold
20,683
– – ﹤0.01% 1645
2023
Q2 		$18.6K Buy
+20,683
New +$18.3K ﹤0.01% 1234

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Pathstone Family Office's CLOV Position: Q3 2023 in Review

Pathstone Family Office held its Clover Health Investments (CLOV) position steady in Q3 2023 at 20,683 shares worth $22.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1645.

Pathstone Family Office first reported a position in CLOV in Q2 2023 and has held it in 2 quarters since. 143 funds tracked by Wall St. Rank hold CLOV as of Q3 2023.

  • Pathstone Family Office held 20,683 shares of Clover Health Investments worth $22.3K as of Q3 2023.
  • Pathstone Family Office left its Clover Health Investments share count unchanged in Q3 2023.
  • Clover Health Investments made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1645 holding.
  • Pathstone Family Office first reported a position in Clover Health Investments in Q2 2023 and has held it in 2 quarters since.
  • 143 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.